Medscape Medical News
- Alert FDA Clears Low-Level Laser Device for 'Whole Body' Pain
- Alert FDA Approves Drug Trio for UTI, Intra-abdominal Infection
- Alert FDA Approves Gadobutrol (Gadavist) Contrast Agent for Cardiac MR
- Alert FDA OKs Immunoglobulin Xembify for Primary Immunodeficiencies
- Alert FDA Approves Selinexor for Refractory Multiple Myeloma
- Alert FDA OKs New Formulation of Tiopronin for Cystinuria
- Alert FDA Expands Indication for Platelet Booster Avatrombopag
- Alert FDA Approves First Drug for Neuromyelitis Optica
- Alert FDA OKs First Treatment for Chronic Rhinosinusitis With Polyps
- Alert FDA OKs Botox for Upper Limb Spasticity in Children
- Alert FDA Approves New Libido-Boosting Drug for Premenopausal Women
- Alert FDA Expands Use of Symdeko for Cystic Fibrosis to Younger Children
- Alert FDA OKs Liraglutide for Use in Youth With Type 2 Diabetes
- Alert Pembro Now Approved for First-Line Use in Head and Neck Cancer
- Alert FDA Approves First Chemoimmunotherapy for R/R Lymphoma Type
- Alert FDA Clears First Device for IBS Pain Relief in Teens
- Alert ADA 2019 Avoid Fingersticks for Diabetes Dosing Decisions With Eversense
- Alert FDA OKs Two Self-Administered Options for Mepolizumab (Nucala)
- Alert Galcanezumab (Emgality) Gets FDA OK for Cluster Headache
- Alert Dual Antibiotic Zerbaxa Gets FDA Nod for Bacterial Pneumonia